Bespoke Extracts (BSPK) Shareholder's Equity Growth (3y) (2014 - 2025)
Bespoke Extracts (BSPK) Shareholder's Equity Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Bespoke Extracts | - | - | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -54.32% |
| Jun 30, 2025 | -50.19% |
| Mar 31, 2025 | -46.98% |
| Nov 30, 2021 | 45.70% |
| Aug 31, 2021 | 0.73% |
| May 31, 2021 | -19.90% |
| Feb 28, 2021 | 27.39% |
| Nov 30, 2020 | -22.51% |
| Aug 31, 2020 | -23.59% |
| May 31, 2020 | -54.02% |
| Feb 29, 2020 | -12.08% |
| Nov 30, 2019 | 42.53% |
| Aug 31, 2019 | 34.74% |
| May 31, 2019 | 62.75% |
| Feb 28, 2019 | -295.30% |
| Nov 30, 2018 | -70.17% |
| Aug 31, 2018 | -54.70% |
| May 31, 2018 | -31.62% |
| Feb 28, 2018 | -39.64% |
| Nov 30, 2017 | -31.55% |